Crystal Kung Minkoff admits temptation to try Ozempic: ‘It’s not a good place for me’
‘Real Housewives’ star said she ‘would be lying’ if she said she ‘hadn’t thought about’ taking diabetes drug for weight loss
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Crystal Kung Minkoff has spoken about the temptation to take the drug Ozempic, despite her long-standing history with eating disorders.
The Real Housewives of Beverly Hills star has spoken candidly over the years about her struggles with both bulimia and body dysmorphia.
Amid the rise in people taking Ozempic and other injectable prescription medications created for people with type 2 diabetes to lose weight, Kung Minkoff discussed her own relationship to the drug.
The reality star stressed that she was in a “really good place” with her eating disorder recovery and felt taking the drug may be detrimental.
“Of course I’ve thought about it, but it’s not a good place for me, personally for my recovery,” she told Page Six.
“From someone who has struggled [with an eating disorder] their whole life, I’ve always looked for things to fix it for me. I’ve never judged or looked down on anyone that finds [a] different avenue.”
Stressing that she “would be lying” if she said she “hadn’t thought about it”, Kung Minkoff added: “And then I have to check myself if that’s right for my recovery and I’m in a very specific situation.”
Ozempic – a brand name for semaglutide – works by mimicking a hormone called GLP1, which is the hormone that is released after you eat to let you know you’re full. Users experience a loss of appetite and often lose weight as a result.
Ozempic is available in the UK from the NHS for the treatment of diabetes, while another semaglutide drug, Wegovy, is expected soon to be available in the UK with the intention of helping people to lose weight.
However, the prevalence of Ozempic as a weight-loss aid has led to global shortages impacting people with diabetes.
“From what I understand, there’s a shortage for people with diabetes in which case I think people should completely stop using it… for just vanity if that’s really the case,” Kung Minkoff said.
“That’s my issue with it. It’s really about making sure people who really need it first get it. Other than that, it’s really people’s decision. It can be private, it can be public, it’s on them.”
For anyone struggling with the issues raised in this piece, eating disorder charity Beat’s helpline is available 365 days a year on 0808 801 0677. You can visit their website here.
NCFED offers information, resources and counselling for those suffering from eating disorders, as well as their support networks. They can be reached by phone on 845 838 2040 or their website here.
This article was amended on April 26 2023 to correct an inaccurate reference to the availability of Ozempic in the UK.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments